deltatrials
Recruiting OBSERVATIONAL NCT06625216

Severe Asthma Network Italy (SANI)

Observatory of Patients With Severe Asthma and Potential Eligible Patients for Treatment With Biological Drugs

Sponsor: Societa Italiana di Pneumologia

Conditions Severe Asthma
Updated 2 times since 2024 Last updated: Apr 23, 2026 Started: Feb 17, 2017 Primary completion: Feb 17, 2027 Completion: Feb 17, 2037
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Severe Asthma, this trial is actively recruiting participants. The trial is conducted by Societa Italiana di Pneumologia and has accumulated 2 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2024 – ~May 2026 · 18 months · monthly snapshotRecruitingMay 4, 2026 – present · 4 months · daily APIRecruiting

Change History

2 versions recorded
  1. May 4, 2026 — Present [daily]

    Recruiting

  2. Nov 2024 — May 2026 [monthly]

    Recruiting

    First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

The goal of this registry is collecting data of severe asthma patients, recruited by specialized centers, in a real life setting, homogeneously placed on a database management system to follow them over the time. The information recorded will provide: 1. The collection of homogeneous clinical, functional and biologic data of patients with severe asthma in a real life setting. 2. The evaluation of adherence to treatment in real life. 3. The clinical eligibility of patients treated with biologics. 4. The evaluation of patients' clinical response to each treatment. 5. The monitoring of tolerability and safety. 6. The long-term follow up of patients with severe asthma.

Contact Information

Sponsor contact:
  • Societa Italiana di Pneumologia
  • Società Italiana di Allergologia, Asma e Immunologia Clinica
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations